Last edition
News about
GENESIS Pharma Secures Exclusive Rights to Commercialise Donidalorsen Across 14 CEE Markets
GENESIS Pharma, a regional biopharma company specialising in the commercialisation of innovative medicines in Central and Eastern Europe (CEE), has entered into an exclusive agreement with Otsuka Pharmaceutical Europe Ltd., the European arm of Otsuka Pharmaceutical Co., Ltd., for the distribution and commercialisation of donidalorsen.
ADEL Signs USD 1.04 Billion Global Licensing Deal with Sanofi for Alzheimer's Drug
ADEL has signed a global licensing deal with Sanofi for its investigational Alzheimer’s therapy ADEL-Y01, valued at up to USD 1.04 billion, including a USD 80 million upfront payment, milestone payments and royalties.
Parliamentary Panel Calls for Faster, Fully Digitised Medical Device Approvals at CDSCO
The Parliamentary Standing Committee on Health and Family Welfare has urged the Department of Health to ensure complete digitisation and automation of the medical device licensing process at the Central Drugs Standard Control Organisation (CDSCO).
Viva Biotech-Backed Arthrosi Enters USD 1.5 Billion Acquisition Deal with Sobi
Biovitrum AB (Sobi) has entered into an acquisition agreement with Viva Biotech–backed Arthrosi Therapeutics, with a total deal value of up to USD 1.5 billion, including USD 950 million upfront and up to USD 550 million in contingent payments, subject to closing in the first half of 2026.
Akums Launches Enhanced Gabapentin ER Formulation for PHN
Akums Drugs and Pharmaceutical has introduced an enhanced Gabapentin Extended-Release (ER) formulation powered by its RetenEx technology for the management of postherpetic neuralgia (PHN), a chronic neuropathic pain condition that affects around 10-20 percent of patients following a shingles outbreak.
Novartis Breaks Ground on Flagship Manufacturing Hub in North Carolina
Novartis has officially begun construction of its flagship manufacturing hub in North Carolina, reinforcing its commitment to end-to-end production of key medicines for US patients. The project, highlighted by FDA Commissioner Marty Makary and Governor Josh Stein, underscores Novartis’ ongoing investment and growth in the US pharmaceutical sector.
Odisha to Host Pharma Summit 2025, Unveil New Pharma and Medical Devices Policy
The summit will bring together pharmaceutical and medical devices manufacturers, startups, innovators, healthcare experts, investors, and other industry stakeholders to explore opportunities within Odisha’s growing pharmaceuticals and healthcare manufacturing sector.
India Identifies 300 Products to Boost Exports to Russia
The Indian government has identified around 300 products with strong potential to significantly increase exports to Russia, as part of efforts to strengthen bilateral trade ties and move towards a long-term trade target of USD 100 billion by 2030.
Biocon Launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide in Netherlands
Biocon has launched its GLP-1 drug–device combination, Liraglutide, in the Netherlands, where it will be marketed under the brand names Diavorin for diabetes and Vobexoryn for chronic weight management.
Senores Pharma Wins US FDA Approval for Deferiprone Tablets, Launched by Dr Reddy's
Senores Pharmaceuticals has announced the approval and US launch of Deferiprone Tablets USP (500 mg and 1000 mg), to be marketed by Dr Reddy’s Laboratories Inc.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy